164 related articles for article (PubMed ID: 26634251)
1. Liver ChIP-seq analysis in FGF19-treated mice reveals SHP as a global transcriptional partner of SREBP-2.
Kim YC; Byun S; Zhang Y; Seok S; Kemper B; Ma J; Kemper JK
Genome Biol; 2015 Dec; 16():268. PubMed ID: 26634251
[TBL] [Abstract][Full Text] [Related]
2. Small Heterodimer Partner and Fibroblast Growth Factor 19 Inhibit Expression of NPC1L1 in Mouse Intestine and Cholesterol Absorption.
Kim YC; Byun S; Seok S; Guo G; Xu HE; Kemper B; Kemper JK
Gastroenterology; 2019 Mar; 156(4):1052-1065. PubMed ID: 30521806
[TBL] [Abstract][Full Text] [Related]
3. SREBP-2 negatively regulates FXR-dependent transcription of FGF19 in human intestinal cells.
Miyata M; Hata T; Yamazoe Y; Yoshinari K
Biochem Biophys Res Commun; 2014 Jan; 443(2):477-82. PubMed ID: 24321096
[TBL] [Abstract][Full Text] [Related]
4. Bile acid signal-induced phosphorylation of small heterodimer partner by protein kinase Cζ is critical for epigenomic regulation of liver metabolic genes.
Seok S; Kanamaluru D; Xiao Z; Ryerson D; Choi SE; Suino-Powell K; Xu HE; Veenstra TD; Kemper JK
J Biol Chem; 2013 Aug; 288(32):23252-63. PubMed ID: 23824184
[TBL] [Abstract][Full Text] [Related]
5. High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis.
Schaap FG; van der Gaag NA; Gouma DJ; Jansen PL
Hepatology; 2009 Apr; 49(4):1228-35. PubMed ID: 19185005
[TBL] [Abstract][Full Text] [Related]
6. A postprandial FGF19-SHP-LSD1 regulatory axis mediates epigenetic repression of hepatic autophagy.
Byun S; Kim YC; Zhang Y; Kong B; Guo G; Sadoshima J; Ma J; Kemper B; Kemper JK
EMBO J; 2017 Jun; 36(12):1755-1769. PubMed ID: 28446510
[TBL] [Abstract][Full Text] [Related]
7. Ligand-dependent regulation of the activity of the orphan nuclear receptor, small heterodimer partner (SHP), in the repression of bile acid biosynthetic CYP7A1 and CYP8B1 genes.
Miao J; Choi SE; Seok SM; Yang L; Zuercher WJ; Xu Y; Willson TM; Xu HE; Kemper JK
Mol Endocrinol; 2011 Jul; 25(7):1159-69. PubMed ID: 21566081
[TBL] [Abstract][Full Text] [Related]
8. The nuclear receptor FXR uncouples the actions of miR-33 from SREBP-2.
Tarling EJ; Ahn H; de Aguiar Vallim TQ
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):787-95. PubMed ID: 25593129
[TBL] [Abstract][Full Text] [Related]
9. Nuclear receptors HNF4α and LRH-1 cooperate in regulating Cyp7a1 in vivo.
Kir S; Zhang Y; Gerard RD; Kliewer SA; Mangelsdorf DJ
J Biol Chem; 2012 Nov; 287(49):41334-41. PubMed ID: 23038264
[TBL] [Abstract][Full Text] [Related]
10. Bile acid signaling pathways increase stability of Small Heterodimer Partner (SHP) by inhibiting ubiquitin-proteasomal degradation.
Miao J; Xiao Z; Kanamaluru D; Min G; Yau PM; Veenstra TD; Ellis E; Strom S; Suino-Powell K; Xu HE; Kemper JK
Genes Dev; 2009 Apr; 23(8):986-96. PubMed ID: 19390091
[TBL] [Abstract][Full Text] [Related]
11. Regulation of hepatic metabolic pathways by the orphan nuclear receptor SHP.
Boulias K; Katrakili N; Bamberg K; Underhill P; Greenfield A; Talianidis I
EMBO J; 2005 Jul; 24(14):2624-33. PubMed ID: 15973435
[TBL] [Abstract][Full Text] [Related]
12. Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis.
Byun S; Kim DH; Ryerson D; Kim YC; Sun H; Kong B; Yau P; Guo G; Xu HE; Kemper B; Kemper JK
Nat Commun; 2018 Jul; 9(1):2590. PubMed ID: 29968724
[TBL] [Abstract][Full Text] [Related]
13. Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet.
Muraoka T; Aoki K; Iwasaki T; Shinoda K; Nakamura A; Aburatani H; Mori S; Tokuyama K; Kubota N; Kadowaki T; Terauchi Y
Metabolism; 2011 May; 60(5):617-28. PubMed ID: 20673929
[TBL] [Abstract][Full Text] [Related]
14. FGF19 (fibroblast growth factor 19) as a novel target gene for activating transcription factor 4 in response to endoplasmic reticulum stress.
Shimizu M; Li J; Maruyama R; Inoue J; Sato R
Biochem J; 2013 Feb; 450(1):221-9. PubMed ID: 23205607
[TBL] [Abstract][Full Text] [Related]
15. Chenodeoxycholic Acid Modulates Bile Acid Synthesis Independent of Fibroblast Growth Factor 19 in Primary Human Hepatocytes.
Johansson H; Søndergaard JN; Jorns C; Kutter C; Ellis ECS
Front Endocrinol (Lausanne); 2020; 11():554922. PubMed ID: 33692750
[TBL] [Abstract][Full Text] [Related]
16. Farnesoid X receptor-dependent and -independent pathways mediate the transcriptional control of human fibroblast growth factor 19 by vitamin A.
Jahn D; Sutor D; Dorbath D; Weiß J; Götze O; Schmitt J; Hermanns HM; Geier A
Biochim Biophys Acta; 2016 Feb; 1859(2):381-92. PubMed ID: 26723851
[TBL] [Abstract][Full Text] [Related]
17. Glycosphingolipid deficiency increases the sterol regulatory element-mediated gene transcription.
Ishitsuka R; Hirabayashi Y; Kobayashi T
Biochem Biophys Res Commun; 2009 Jan; 378(2):240-3. PubMed ID: 19017528
[TBL] [Abstract][Full Text] [Related]
18. Antibody-mediated inhibition of fibroblast growth factor 19 results in increased bile acids synthesis and ileal malabsorption of bile acids in cynomolgus monkeys.
Pai R; French D; Ma N; Hotzel K; Plise E; Salphati L; Setchell KD; Ware J; Lauriault V; Schutt L; Hartley D; Dambach D
Toxicol Sci; 2012 Apr; 126(2):446-56. PubMed ID: 22268002
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide localization of SREBP-2 in hepatic chromatin predicts a role in autophagy.
Seo YK; Jeon TI; Chong HK; Biesinger J; Xie X; Osborne TF
Cell Metab; 2011 Apr; 13(4):367-375. PubMed ID: 21459322
[TBL] [Abstract][Full Text] [Related]
20. Intestinal FGF15/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A.
Kim YC; Seok S; Zhang Y; Ma J; Kong B; Guo G; Kemper B; Kemper JK
Nat Commun; 2020 Nov; 11(1):5969. PubMed ID: 33235221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
